New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 14, 2014
07:37 EDTSUPNSupernus receives FDA fast track designation for SPN-810
Supernus Pharmaceuticals announced that the United States Food and Drug Administration has granted fast track designation for SPN-810 for the treatment of impulsive aggression in attention deficit hyperactivity disorder. This product candidate is expected to enter Phase III testing, with patient dosing commencing during 2015.
News For SUPN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 10, 2014
07:35 EDTSUPNSupernus announces Paragraph IV ANDA filing for Oxtellar XR
Subscribe for More Information
December 9, 2014
07:36 EDTSUPNSupernus announces Paragraph IV ANDA filing for Trokendi XR
Subscribe for More Information
December 8, 2014
17:24 EDTSUPNOrchard Hill lowers stake in Supernus to 4.99% from 7.0%
Stake includes convertible notes.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use